CN1250548C
(zh)
|
2001-04-17 |
2006-04-12 |
大日本住友制药株式会社 |
新的腺嘌呤衍生物
|
BR0314761A
(pt)
|
2002-09-27 |
2005-07-26 |
Sumitomo Pharma |
Composto de adenina e seu uso
|
CA2537450C
(en)
*
|
2003-09-05 |
2012-04-17 |
Anadys Pharmaceuticals, Inc. |
Administration of tlr7 ligands and prodrugs thereof for treatment of infection by hepatitis c virus
|
NZ549903A
(en)
|
2004-03-26 |
2010-04-30 |
Astrazeneca Ab |
9-substituted 8-oxoadenine compound
|
US20090324551A1
(en)
|
2005-08-22 |
2009-12-31 |
The Regents Of The University Of California Office Of Technology Transfer |
Tlr agonists
|
KR20080085232A
(ko)
|
2006-02-17 |
2008-09-23 |
화이자 리미티드 |
Tlr7 조절제로서 3-데아자퓨린 유도체
|
WO2008004948A1
(en)
|
2006-07-05 |
2008-01-10 |
Astrazeneca Ab |
8-oxoadenine derivatives acting as modulators of tlr7
|
TW200831105A
(en)
|
2006-12-14 |
2008-08-01 |
Astrazeneca Ab |
Novel compounds
|
PL2510946T3
(pl)
|
2007-02-07 |
2015-12-31 |
Univ California |
Koniugaty syntetycznych agonistów tlr i ich zastosowania
|
ES2373616T3
(es)
|
2007-03-19 |
2012-02-07 |
Astrazeneca Ab |
Compuestos de 8-oxo-adenina 9 sustituidos como moduladores del receptor de tipo toll (tlr7).
|
ES2457316T3
(es)
|
2007-03-19 |
2014-04-25 |
Astrazeneca Ab |
Compuestos 8-oxo-adenina 9 sustituidos como moduladores del receptor similares a toll (TLR7)
|
PE20081887A1
(es)
*
|
2007-03-20 |
2009-01-16 |
Dainippon Sumitomo Pharma Co |
Nuevo compuesto de adenina
|
US8044056B2
(en)
|
2007-03-20 |
2011-10-25 |
Dainippon Sumitomo Pharma Co., Ltd. |
Adenine compound
|
US8436178B2
(en)
|
2007-05-08 |
2013-05-07 |
Astrazeneca Ab |
Imidazoquinolines with immuno-modulating properties
|
PE20091236A1
(es)
|
2007-11-22 |
2009-09-16 |
Astrazeneca Ab |
Derivados de pirimidina como immunomoduladores de tlr7
|
PE20091156A1
(es)
|
2007-12-17 |
2009-09-03 |
Astrazeneca Ab |
Sales de (3-{[[3-(6-amino-2-butoxi-8-oxo-7,8-dihidro-9h-purin-9-il)propil](3-morfolin-4-ilpropil)amino]metil}fenil)acetato de metilo
|
WO2009091032A1
(ja)
|
2008-01-17 |
2009-07-23 |
Dainippon Sumitomo Pharma Co., Ltd. |
アデニン化合物の製造方法
|
WO2010088924A1
(en)
|
2009-02-06 |
2010-08-12 |
Telormedix Sa |
Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration
|
GB0908772D0
(en)
|
2009-05-21 |
2009-07-01 |
Astrazeneca Ab |
New salts 756
|
US20120122867A1
(en)
|
2009-05-21 |
2012-05-17 |
Nicholas James Bennet |
Novel pyrimidine derivatives and their use in the treatment of cancer and further diseases
|
CA2777824C
(en)
|
2009-10-22 |
2016-11-29 |
Gilead Sciences, Inc. |
Derivatives of purine or deazapurine useful for the treatment of (inter alia) viral infections
|
US9050319B2
(en)
|
2010-04-30 |
2015-06-09 |
Telormedix, Sa |
Phospholipid drug analogs
|
CN103221067B
(zh)
|
2010-04-30 |
2016-01-06 |
泰勒麦迪克斯公司 |
磷脂药物类似物
|
EP2651937B8
(en)
|
2010-12-16 |
2016-07-13 |
Sumitomo Dainippon Pharma Co., Ltd. |
Imidazo[4,5-c]quinolin-1-yl derivative useful in therapy
|
ES2627433T3
(es)
|
2010-12-17 |
2017-07-28 |
Sumitomo Dainippon Pharma Co., Ltd. |
Derivados de purina
|
MY178053A
(en)
|
2012-05-18 |
2020-09-30 |
Sumitomo Dainippon Pharma Co Ltd |
Carboxylic acid compounds
|
NZ735648A
(en)
*
|
2015-05-08 |
2023-06-30 |
Hoffmann La Roche |
Novel sulfonimidoylpurinone compounds and derivatives for the treatment and prophylaxis of virus infection
|
US11697851B2
(en)
|
2016-05-24 |
2023-07-11 |
The Regents Of The University Of California |
Early ovarian cancer detection diagnostic test based on mRNA isoforms
|
TWI671300B
(zh)
|
2016-08-29 |
2019-09-11 |
瑞士商赫孚孟拉羅股份公司 |
用於治療及預防病毒感染之新穎7–經取代磺醯亞胺醯基嘌呤酮化合物及衍生物
|
EP3970750A1
(en)
|
2016-09-13 |
2022-03-23 |
F. Hoffmann-La Roche AG |
Combined treatment with a tlr7 agonist and an hbv capsid assembly inhibitor
|
JP7328977B2
(ja)
*
|
2018-02-12 |
2023-08-17 |
エフ. ホフマン-ラ ロシュ アーゲー |
ウイルス感染の処置および予防のための新規のスルホン化合物および誘導体
|
EP3758707A1
(en)
|
2018-02-28 |
2021-01-06 |
F. Hoffmann-La Roche AG |
7-substituted sulfonimidoylpurinone compounds and derivatives for the treatment and prophylaxis of liver cancer
|